These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37991922)

  • 41. Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease.
    Lázaro DF; Pavlou MAS; Outeiro TF
    Exp Neurol; 2017 Dec; 298(Pt B):162-171. PubMed ID: 28526239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of functional alpha-synuclein: a toxic event in Parkinson's disease?
    Kanaan NM; Manfredsson FP
    J Parkinsons Dis; 2012; 2(4):249-67. PubMed ID: 23938255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer.
    Musgrove RE; Helwig M; Bae EJ; Aboutalebi H; Lee SJ; Ulusoy A; Di Monte DA
    J Clin Invest; 2019 Jun; 129(9):3738-3753. PubMed ID: 31194700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
    Daher JP
    Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-translational modification of α-synuclein in Parkinson's disease.
    Barrett PJ; Timothy Greenamyre J
    Brain Res; 2015 Dec; 1628(Pt B):247-253. PubMed ID: 26080075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients.
    Dieriks BV; Park TI; Fourie C; Faull RL; Dragunow M; Curtis MA
    Sci Rep; 2017 Feb; 7():42984. PubMed ID: 28230073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's disease.
    Matsui H; Ito S; Matsui H; Ito J; Gabdulkhaev R; Hirose M; Yamanaka T; Koyama A; Kato T; Tanaka M; Uemura N; Matsui N; Hirokawa S; Yoshihama M; Shimozawa A; Kubo SI; Iwasaki K; Hasegawa M; Takahashi R; Hirai K; Kakita A; Onodera O
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2214652120. PubMed ID: 37252975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
    Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
    J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
    George S; Brundin P
    J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.
    Alvarez-Erviti L; Seow Y; Schapira AH; Rodriguez-Oroz MC; Obeso JA; Cooper JM
    Cell Death Dis; 2013 Mar; 4(3):e545. PubMed ID: 23492776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson's disease.
    Lobanova E; Whiten D; Ruggeri FS; Taylor CG; Kouli A; Xia Z; Emin D; Zhang YP; Lam JYL; Williams-Gray CH; Klenerman D
    Brain; 2022 Apr; 145(2):632-643. PubMed ID: 34410317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-invasive systemic viral delivery of human alpha-synuclein mimics selective and progressive neuropathology of Parkinson's disease in rodent brains.
    Bérard M; Martínez-Drudis L; Sheta R; El-Agnaf OMA; Oueslati A
    Mol Neurodegener; 2023 Nov; 18(1):91. PubMed ID: 38012703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.
    Herman S; Djaldetti R; Mollenhauer B; Offen D
    Brain; 2023 Jan; 146(1):209-224. PubMed ID: 35881523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.
    Garcia-Esparcia P; Hernández-Ortega K; Koneti A; Gil L; Delgado-Morales R; Castaño E; Carmona M; Ferrer I
    Acta Neuropathol Commun; 2015 Dec; 3():76. PubMed ID: 26621506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.
    Lau HHC; Martinez-Valbuena I; So RWL; Mehra S; Silver NRG; Mao A; Stuart E; Schmitt-Ulms C; Hyman BT; Ingelsson M; Kovacs GG; Watts JC
    Acta Neuropathol Commun; 2023 May; 11(1):72. PubMed ID: 37138318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
    Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
    Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
    Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
    Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prying into the Prion Hypothesis for Parkinson's Disease.
    Brundin P; Melki R
    J Neurosci; 2017 Oct; 37(41):9808-9818. PubMed ID: 29021298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.